In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Diatos raises total of €9mm in second round

Executive Summary

Diatos SA (technologies for getting therapeutics into cells and cell nuclei) has raised €6.5mm ($6.9mm) in its second financing. Credit Lyonnais Private Equity led this round, joined by Diatos' existing investors Sofinnova Partners, GIMV, InterWest, AGF Private Equity, Societe Generale Asset Management, and Sopartec.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies